These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The 50% effective dose (ED50a) of seasonal spilt influenza vaccine in mice]. Huang BY; Wang XP; Tang WJ; Wang WL; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):92-5. PubMed ID: 21863626 [TBL] [Abstract][Full Text] [Related]
3. Extremely low vaccine effectiveness against influenza H3N2 in the elderly during the 2012/2013 flu season. Kelvin DJ; Farooqui A J Infect Dev Ctries; 2013 Mar; 7(3):299-301. PubMed ID: 23493013 [No Abstract] [Full Text] [Related]
4. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823 [TBL] [Abstract][Full Text] [Related]
5. Seasonal trivalent influenza vaccine for 2010-2011. Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341 [No Abstract] [Full Text] [Related]
10. Comparative efficacy of influenza vaccines. Narayan KM; del Rio C N Engl J Med; 2010 Jan; 362(2):179-80; author reply 180-1. PubMed ID: 20071712 [No Abstract] [Full Text] [Related]
11. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Valenciano M; Kissling E; Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183 [TBL] [Abstract][Full Text] [Related]
12. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine. Myers CA; Faix DJ; Blair PJ Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631 [No Abstract] [Full Text] [Related]
13. Influenza vaccine 2008-2009. Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032 [TBL] [Abstract][Full Text] [Related]
15. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home. Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941 [TBL] [Abstract][Full Text] [Related]
16. [Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009]. Piţigoi D; Lupulescu E; Alexandrescu V; Băeţel A; Sbârcea C; Ioniţă E; Săvulescu C; Duca E; Sima C; Truică C; Ibram S; Bobîrnac A; Militaru L; Arion M Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):109-16. PubMed ID: 20422925 [TBL] [Abstract][Full Text] [Related]
17. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Apr; 61(14):237-41. PubMed ID: 22495226 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Baxter R; Patriarca PA; Ensor K; Izikson R; Goldenthal KL; Cox MM Vaccine; 2011 Mar; 29(12):2272-8. PubMed ID: 21277410 [TBL] [Abstract][Full Text] [Related]
19. Using surveillance to evaluate influenza vaccine effectiveness. Jackson LA J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916 [No Abstract] [Full Text] [Related]
20. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13--a rapid epidemiological and virological assessment. Bragstad K; Emborg H; Fischer TK; Voldstedlund M; Gubbels S; Andersen B; Molbak K; Krause T Euro Surveill; 2013 Feb; 18(6):. PubMed ID: 23410258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]